# Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF

> **NCT04444245** · PHASE1 · UNKNOWN · sponsor: **Black Tie Medical, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Ovarian Failure
- Perimenopausal Disorder
- Hormone Disturbance

## Interventions

- **PROCEDURE:** lipoaspiration harvest tSVF
- **PROCEDURE:** Platelet Rich Plasma
- **PROCEDURE:** Endovaginal Ultrasound
- **DEVICE:** Cellular Isolation cSVF
- **DRUG:** Normal Saline (NS) .9% 10 mL Injection
- **DEVICE:** emulsification tSVF

## Key facts

- **NCT ID:** NCT04444245
- **Lead sponsor:** Black Tie Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-15
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-08-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444245, "Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04444245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*